Ranok Therapeutics Competitors and Similar CompaniesClear all

Ranok Therapeutics's competitors and similar companies include Mingsight Pharmaceuticals, Indivumed and Allucent TX.
Ranok Therapeutics
Ranok Therapeutics
Ranok Therapeutics is a company that develops targeted protein degradation for novel therapeutics discovery and development.
Mingsight Pharmaceuticals
Mingsight Pharmaceuticals
Mingsight Pharmaceuticals is a company that specializes in protein kinase C (PKC) inhibitors.
Indivumed
Indivumed
Indivumed is an oncology company developing individualized cancer therapy.
Allucent TX
Allucent TX
Allucent (also known as Pharm-Olam) is a contract research organization offering clinical research services (Phase I-IV) to the pharmaceutical, biotechnology, and medical device industries.
Founding Date
Founding Date
2018
Founding Date
2009
Founding Date
2002
Founding Date
1994
Type
Type
Private
Type
Private
Type
Private
Type
Subsidiary
Tags
Locations
Locations
HQ
Locations
San Diego, US HQ
Locations
Hamburg, DE HQ
Frederick, US
Locations
Chicago, US HQ
Scherpenheuvel Zichem, BE
Sao Paulo, BR
Montréal, CA
Zagreb, HR
Prague, CZ
Paris, FR
see more
Employees
Employees
11
Employees
4
Employees
964% decrease
Employees
4831% decrease

Funding

Latest funding round
Latest funding round
$ 40m (almost 5 years ago)
Latest funding round
N/A
Latest funding round
$ 48m (over 8 years ago)
Latest funding round
N/A
Total funding raised
Total funding raised
$ 40m
Total funding raised
N/A
Total funding raised
$ 48m
Total funding raised
N/A
For sources of this data, please see the company profile

View Company Profiles

Mingsight Pharmaceuticals
HQ
San Diego, US
Employees
4

Mingsight Pharmaceuticals is a company that specializes in protein kinase C (PKC) inhibitors.

View company
Indivumed
HQ
Hamburg, DE
Employees
96↓ 4% decrease

Indivumed is an oncology company developing individualized cancer therapy.

View company
Allucent TX
HQ
Chicago, US

Allucent (also known as Pharm-Olam) is a contract research organization offering clinical research services (Phase I-IV) to the pharmaceutical, biotechnology, and medical device industries.

View company